From NIH to ATM
Alternative Going Mainstream? Biotechs Find Funding Options
By Jennifer Boggs
Monday, March 7, 2011
If the latest economic downturn has taught anything at all, it's that there will always be more than one way to fund a biotech company.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.